Stay updated on Ibrutinib+Bendamustine/Rituximab in Mantle Cell Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Ibrutinib+Bendamustine/Rituximab in Mantle Cell Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ibrutinib+Bendamustine/Rituximab in Mantle Cell Lymphoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page revision label has been updated from Revision: v3.5.3 to Revision: v3.5.4. This indicates a newer page version reflecting internal updates rather than changes to user-visible content.
    Difference
    0.0%
    Check dated 2026-05-15T15:32:11.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page’s displayed platform/footer revision was updated from v3.5.2 to v3.5.3, reflecting a site version change rather than any change to the study record content.
    Difference
    0.0%
    Check dated 2026-04-24T06:20:47.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-17T02:39:16.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-19T04:51:49.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-12T00:48:05.000Z thumbnail image
  8. Check
    98 days ago
    Change Detected
    Summary
    A new revision label 'Revision: v3.4.2' was added, and the funding-status notice and 'Revision: v3.4.1' were removed. These are administrative changes that do not alter study information or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T12:41:33.000Z thumbnail image

Stay in the know with updates to Ibrutinib+Bendamustine/Rituximab in Mantle Cell Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ibrutinib+Bendamustine/Rituximab in Mantle Cell Lymphoma Clinical Trial page.